These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4029480)

  • 1. Nutrition and somatomedin--XII. Fractionation of somatomedins and somatomedin inhibitors in normal and diabetic rats.
    Phillips LS; Bajaj VR; Fusco AC; Keery KM; Goldstein S
    Int J Biochem; 1985; 17(5):597-603. PubMed ID: 4029480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition and somatomedin. XI. Studies of somatomedin inhibitors in rats with streptozotocin-induced diabetes.
    Phillips LS; Bajaj VR; Fusco AC; Matheson CK
    Diabetes; 1983 Dec; 32(12):1117-25. PubMed ID: 6653901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition and somatomedin. XIV. Altered levels of somatomedins and somatomedin inhibitors in rats with streptozotocin-induced diabetes.
    Phillips LS; Fusco AC; Unterman TG
    Metabolism; 1985 Aug; 34(8):765-70. PubMed ID: 3160912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutrition and somatomedin. VI. Somatomedin activity and somatomedin inhibitory activity in sera from normal and diabetic rats.
    Phillips LS; Belosky DC; Young HS; Reichard LA
    Endocrinology; 1979 May; 104(5):1519-24. PubMed ID: 35342
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition and somatomedin: nutritionally regulated release of somatomedins and somatomedin inhibitors from perfused livers in rats.
    Goldstein S; Phillips LS
    Metabolism; 1989 Aug; 38(8):745-52. PubMed ID: 2761412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition and somatomedin. V. Action and measurement of somatomedin inhibitor(s) in serum from diabetic rats.
    Phillips LS; Belosky DC; Reichard LA
    Endocrinology; 1979 May; 104(5):1513-8. PubMed ID: 35341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating growth factor studies in growth plate versus resting cartilage in vitro. II. Recognition of growth factors in rat serum.
    Phillips LS; Weiss LJ; Matheson CK
    Endocrinology; 1983 Oct; 113(4):1494-502. PubMed ID: 6352247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic conversion of insulin-like growth factors to an acidic form(s).
    Kuffer AD; Herington AC
    Biochem J; 1984 Oct; 223(1):97-103. PubMed ID: 6388567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition and somatomedin. XVI: Somatomedins and somatomedin inhibitors in fasted and refed rats.
    Phillips LS; Goldstein S; Gavin JR
    Metabolism; 1988 Mar; 37(3):209-16. PubMed ID: 2449597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of somatomedins and somatomedin inhibitors by size exclusion high-performance liquid chromatography.
    Goldstein S; Stivaletta LA; Phillips LS
    J Chromatogr; 1985 May; 339(2):388-93. PubMed ID: 4008578
    [No Abstract]   [Full Text] [Related]  

  • 12. Extraction of cartilage sulfation inhibitors and somatomedins from rat liver.
    Vassilopoulou-Sellin R; Oyedeji CO; Samaan NA
    Endocrinology; 1984 Feb; 114(2):576-81. PubMed ID: 6690293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid effects on somatomedins and somatomedin inhibitors.
    Unterman TG; Phillips LS
    J Clin Endocrinol Metab; 1985 Oct; 61(4):618-26. PubMed ID: 4031007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and somatomedin. XV. Growth plate, growth factor and biologically active somatomedins in rats with streptozotocin-induced diabetes.
    Goldstein S; Unterman TG; Phillips LS
    Ann Nutr Metab; 1987; 31(6):367-77. PubMed ID: 3426154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition and somatomedin. VIII. The "somatomedin inhibitor" in diabetic rat serum is a general inhibitor of growing cartilage.
    Phillips LS; Vassilopoulou-Sellin R; Reichard LA
    Diabetes; 1979 Oct; 28(10):919-24. PubMed ID: 478184
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in serum receptor-reactive somatomedin in diabetes.
    Baxter RC; Brown AS; Turtle JR
    Horm Metab Res; 1979 Mar; 11(3):216-20. PubMed ID: 221310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid effects on IGF-1/somatomedin-C and somatomedin inhibitor in streptozotocin-diabetic rats.
    Hofert JF; Goldstein S; Phillips LS
    Metabolism; 1989 Jun; 38(6):594-600. PubMed ID: 2725299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
    Hey AW; Browne CA; Thorburn GD
    Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats.
    Phillips LS; Young HS
    Diabetes; 1976 Jun; 25(6):516-27. PubMed ID: 132381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition and somatomedin. XXI. Insulin-like growth factor-I and somatomedin inhibitor in streptozotocin-diabetic rats: relation to ketogenesis and gluconeogenesis.
    Gagliardi AR; Goldstein S; Phillips LS
    Metabolism; 1990 Jan; 39(1):75-80. PubMed ID: 2403622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.